Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Daiichi Sankyo Company, Limited DSNKY OTC

Other OTC • Healthcare • Drug Manufacturers - General • JP • USD

SharesGrow Score
94/100
7/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Daiichi Sankyo Company, Limited (DSNKY) — Analyst outlook / Analyst consensus target is. Based on 2 analyst ratings, the consensus is bullish — 2 Buy.

DSNKY Analyst Ratings

Buy
2
Ratings
2 Buy
Based on 2 analysts giving stock ratings to Daiichi Sankyo Company, Limited in the past 3 months
Rating breakdown
Buy
2 100%
100%
Buy
2 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

People Also View

JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
 RHHBY
RHHBY
Roche Holding AG
$51.02
+0.65%
 AZN
AZN
AstraZeneca PLC
$204.38
+1.06%
 MRK
MRK
Merck & Co., Inc.
$119.96
-0.16%
 NVS
NVS
Novartis AG
$153.38
-0.71%
 AMGN
AMGN
Amgen Inc.
$350.95
+0.32%
 GILD
GILD
Gilead Sciences, Inc.
$140.45
+1.02%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message